KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233,653 | +1.9% | 1,382 | +30.6% | 0.00% | – |
| Q2 2023 | $229,370 | +102.7% | 1,058 | +69.8% | 0.00% | – |
| Q1 2023 | $113,136 | +31.3% | 623 | +43.2% | 0.00% | – |
| Q4 2022 | $86,162 | +30.5% | 435 | +47.5% | 0.00% | – |
| Q3 2022 | $66,000 | +371.4% | 295 | +170.6% | 0.00% | – |
| Q2 2022 | $14,000 | +16.7% | 109 | +13.5% | 0.00% | – |
| Q1 2022 | $12,000 | -78.6% | 96 | -77.5% | 0.00% | – |
| Q4 2021 | $56,000 | +409.1% | 427 | +364.1% | 0.00% | – |
| Q3 2021 | $11,000 | 0.0% | 92 | -2.1% | 0.00% | – |
| Q2 2021 | $11,000 | 0.0% | 94 | +5.6% | 0.00% | – |
| Q1 2021 | $11,000 | +57.1% | 89 | +34.8% | 0.00% | – |
| Q4 2020 | $7,000 | +40.0% | 66 | 0.0% | 0.00% | – |
| Q3 2020 | $5,000 | -78.3% | 66 | -67.6% | 0.00% | – |
| Q2 2020 | $23,000 | +228.6% | 204 | +140.0% | 0.00% | – |
| Q1 2020 | $7,000 | – | 85 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |